← Browse by Condition
Medical Condition
malignant pleural effusion
Total Trials
3
Recruiting Now
3
Trial Phases
Phase 1
ClinicalMetric tracks all active clinical trials for malignant pleural effusion sourced from ClinicalTrials.gov. Each listing includes the NCT identifier, current recruitment status, phase, primary endpoints, sponsor, estimated enrollment, and participating countries — updated daily as new studies open and status changes.
- Recruiting trials currently enrolling participants, with eligibility criteria and age requirements
- Phase 1–4 studies from early safety trials to post-marketing surveillance
- NIH, pharmaceutical sponsor, and academic medical center studies worldwide
- AI-powered plain-language summary available for every trial listing
Trial Phases
Phase 1 2
Top Sponsors
1 trial
1 trial
1 trial
Recruiting Clinical Trials
NCT06421610 Phase 1
Recruiting
OPC5: Pressurized IntraThoracic Aerosol Chemotherapy (PITAC) in Patients With Malignant Pleural Effusion.
Enrollment
20 pts
Location
Denmark
Sponsor
Odense University Hospital
NCT07147270
Recruiting
Impact of Patient Position on Chemical Pleurodesis by Chest Ultrasound
Enrollment
30 pts
Location
Egypt
Sponsor
Ain Shams University
NCT06016179 Phase 1
Recruiting
Tocilizumab Delivered Via Pleural and Peritoneal Catheters in Patients With Advanced Metastatic Cancer
Enrollment
12 pts
Location
United States
Sponsor
Allegheny Singer Research Inst...
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: April 2026 · Data Methodology